Skip to content

Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS)

Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS), a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05980793
Enrollment
90
Registered
2023-08-08
Start date
2023-09-25
Completion date
2029-07-15
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis Finger, Surgery

Brief summary

The goal of this clinical trial is to compare the effects of a surgical and a non-surgical treatment method in patients with osteoarthritis in the proximal interphalangeal (PIP) joint. The main questions it aims to answer are: * Are the treatments effective? * Is the surgical treatment more effective than the non-surgical treatment? Participants will receive surgical treatment (PIP joint denervation) or non surgical treatment (patient education plus exercise). Researchers will compare the non-surgical and surgical groups to see if pain, patient-reported function, quality of life, movement and grip strength differs between the groups.

Detailed description

This is a parallel group, two-arm, randomized, controlled trial comparing the effects of surgical denevation to patient education plus exercise in patients with symptomatic PIP joint osteoarthritis. The research questions are: 1. Does any of the treatments denervation of the PIP-joint and patient education plus exercise decrease pain, improve patient-reported outcomes, grip strength and range of motion (ROM) in PIP-joint osteoarthritis? 2. Does denervation of the PIP-joint decrease pain, and improve patient-reported outcomes grip strength and ROM more effectively than patient education plus exercise for PIP-joint osteoarthritis? Participants will be randomly assigned (1:1) to receive surgical denervation of the PIP-joint or education plus exercise. A block randomization scheme with a fixed block size of 10 will be used. Patients will be stratified according to gender. Sealed opaque envelopes will be used and data analysts will be masked for treatment allocation. Assesments will be made at inclusion, and after 3, 6 and 12 months. The studys primary enpoint is 12 months after intervention.

Interventions

PROCEDUREPIP joint denervation

Surgical denervation of the PIP joint

PROCEDUREPatient education plus exercise

An education plus exercise program

Sponsors

Stockholm South General Hospital
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Data analysts will be masked for treatment allocation

Intervention model description

A parallel group, two-arm, randomized, controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Chronic symptomatic osteoarthritis in the PIP-joint. * Radiological signs of osteoarthritis on posteroanterior and lateral radiographs assessed by the Kellgren-Lawrence classification (grade II-IV) (Kellgren & Lawrence, 1957). * Clinical signs of PIP-joint arthritis.

Exclusion criteria

* Inflammatory arthritis. * Ongoing infection in the hand. * Inability to co-operate with the follow-up protocol. * Intra-articular glucocorticoid, PRP or Hyaluronic acid injections in the affected joint less than 3 months prior to enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Pain on load (change baseline to -12 months)0-12 monthsPain (Numerical Rating Scale, 0-100 points, 100 is a worse outcome)

Secondary

MeasureTime frameDescription
HQ8 (8-item patient questionnaire) change baseline to -3, -6, 12 months0-12 monthsA questionnaire used by Swedish Healthcare Quality Registry for hand surgery (HAKIR), 0-100 points, 100 is a worse outcome.
PRWHE (Patient Rated Wrist/Hand Evaluation) change baseline to -3, 6, 12 months0-12 monthsA questionnaire that measures hand/wrist function (0-100 points, 100 is a worse outcome)
EQ5D-5L change baseline to -3, -6, -12 months0-12 monthsA questionnaire that measures quality of life (0-1 point, 0 is a worse outcome).
Pain at rest (change baseline to -3, -6, -12 months)0-12 monthsPain (Numerical Rating Scale, 0-100 points, 100 is a worse outcome)
Complications0-12 months2PD (Two point discrimination, 0-15mm, 15 indicating a worse outcome)
Additional treatment0-12 monthsNeed for further surgery/treatment
Objective function change baseline to -3, -6, -12 months0-12 monthsRange of motion (goniometer with 5 degrees interval)

Countries

Sweden

Contacts

Primary ContactElin Sward, MD, PhD
elin.sward@regionstockholm.se+46812361000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026